Fluocinolone Acetonide
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 2 | SUPPLYING |
| Fougera Pharmaceuticals, LLC | unknown | 1 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide within the USA
Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient. — Recalling firm: LUPIN SOMERSET — Nationwide in the USA and Puerto Rico
Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis — Recalling firm: LUPIN SOMERSET — Nationwide in the USA
Chemical Contamination — Recalling firm: Novel Laboratories, Inc. — Nationwide
